Home › NDC Lookup › RxCUI directory › RxCUI 756209

Zidovudine 10 MG/ML Oral Solution — RxCUI 756209

RxNorm drug concept · Semantic clinical drug
RxCUI 756209 Semantic clinical drug · SCD ● Current RxNorm concept 4 FDA products 4 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI756209
Official nameZidovudine 10 MG/ML Oral Solution
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asAZT 10 MG/ML Oral Solution; zidovudine 10 MG in 1 mL Oral Solution; zidovudine 10 MG per 1 ML Oral Solution
FDA products mapped4
Package NDCs mapped4
Reported Medicaid activity (SDUD)932 prescriptions · 16 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Zidovudine Injection: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • The injectable form of Retrovir is used when you can't take medicine by mouth — for example, during surgery, labor, or if you're too unwell to swallow. It's given directly into a v...
  • Why am I getting zidovudine as an injection instead of a pill?
  • Yes — this is one of the most important uses of Retrovir. In a well-designed clinical study, treating HIV-positive mothers with zidovudine during pregnancy and labor, and then trea...
  • Can zidovudine really lower the chances of passing HIV to my baby?
📖 Read our full Zidovudine Injection guide →

🕸️ Concept Web — How Zidovudine 10 MG/ML Oral Solution Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Zidovudine 10 MG/ML Oral Solution RxCUI 756209

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Zidovudine 11413
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Retrovir 202791
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Zidovudine Oral Solution 756805
    • Zidovudine Oral Liquid Product 1163027
    • Zidovudine Oral Product 1163028
    • Zidovudine Oral Solution [Retrovir] 756806
    • Retrovir Oral Liquid Product 1182540
    • Retrovir Oral Product 1182541
    • Oral Solution 316968
    • Oral Liquid Product 1151137
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Zidovudine 10 MG/ML SCDC · 317538
  • Zidovudine Oral Solution SCDF · 756805
  • Zidovudine Oral Liquid Product SCDG · 1163027
  • Zidovudine Oral Product SCDG · 1163028

Brand-Name Concepts

  • Zidovudine 10 MG/ML Oral Solution [Retrovir] SBD · 755298
  • Zidovudine 10 MG/ML [Retrovir] SBDC · 564526
  • Zidovudine Oral Solution [Retrovir] SBDF · 756806
  • Retrovir Oral Liquid Product SBDG · 1182540
  • Retrovir Oral Product SBDG · 1182541
  • Retrovir BN · 202791

📦 FDA Products & Package NDCs

4 products · 4 package NDCs
4 package NDCs map to RxCUI 756209 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
49702-0211-20 100 CAPSULE in 1 BOTTLE (49702-211-20) RETROVIR ViiV Healthcare Company 2010-10-28
49702-0212-48 240 mL in 1 BOTTLE (49702-212-48) RETROVIR ViiV Healthcare Company 2010-10-28
49702-0213-26 5 VIAL, SINGLE-USE in 1 CARTON (49702-213-26) / 20 mL in 1... RETROVIR ViiV Healthcare Company 2016-12-01
65862-0048-24 240 mL in 1 BOTTLE (65862-048-24) Zidovudine Aurobindo Pharma Limited 2005-09-19
Observed labelers: ViiV Healthcare Company (3) · Aurobindo Pharma Limited (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🧾 Billing Codes (HCPCS)

Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.
CodeDescriptorMapped packagesSources
J3485 Zidovudine 1 CMS
⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.